Page 6 - Haematologica Vol. 107 - September 2022

2064 Acute Lymphoblastic Leukemia
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin Sabine Kayser et al.
https://doi.org/10.3324/haematol.2021.280433
2072 Acute Lymphoblastic Leukemia
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
Aurélie Cabannes-Hamy et al.
https://doi.org/10.3324/haematol.2021.280078
2081 Bone Marrow Failure
Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children Oded Gilad et al.
https://doi.org/10.3324/haematol.2021.280116
2096 Cell Therapy & Immunotherapy
Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies
David M. Cordas dos Santos et al.
https://doi.org/10.3324/haematol.2021.280189
2108 Chronic Lymphocytic Leukemia
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial Carol Moreno et al.
https://doi.org/10.3324/haematol.2021.279012
2121 Hemostasis
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
Katarina D. Kovacevic et al.
https://doi.org/10.3324/haematol.2021.279948
2133 Hemostasis
The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse
Sachiko Kanaji et al.
https://doi.org/10.3324/haematol.2021.280561
2144 Non-Hodgkin Lymphoma
Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation
Karoline Koch et al.
https://doi.org/10.3324/haematol.2021.279351
2154 Non-Hodgkin Lymphoma
A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas
Xiaoxiao Wang et al.
https://doi.org/10.3324/haematol.2021.279908
2163 Non-Hodgkin Lymphoma
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma
Louise Bouard et al.
https://doi.org/10.3324/haematol.2021.279561
2173 Non-Hodgkin Lymphoma
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study
Marie Emilie Dourthe et al.
https://doi.org/10.3324/haematol.2021.280257
Haematologica | 107 - September 2022
IV